Navigation Links
DrugRisks Announces Yaz Center With Latest Updates on Blood Clot Warnings and Settlements
Date:5/29/2013

Chicago, IL (PRWEB) May 29, 2013

The birth control safety advocates at DrugRisks.com are announcing a new resource center for patients who have taken the contraceptives Yaz or Yasmin. The site contains warnings about the drugs’ alleged link to blood clots and compensation offered by Bayer for victims.

DrugRisks was created to give patients taking popular prescription drugs like Yaz and Yasmin the latest warnings, recalls, studies and legal news. With access to clear information, patients can discuss side effect concerns with their doctor and decide if they need legal advice.

The resource center contains studies from the British Medical Journal* and FDA** showing patients taking birth control pills containing drospirenone, like Yaz and Yasmin, may have an increased risk of developing blood clots.

With a growing number of patients filing a Yaz lawsuit alleging blood clot injuries, cases were consolidated to a special federal Multi-District Litigation court in Illinois (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).

DrugRisks has also learned that the maker of Yaz and Yasmin, Bayer, has spent nearly $1 billion so far to settle around 4,800 claims alleging Yaz blood clots, and will continue to evaluate new claims for settlement on a case-by-case basis***.

Although a federal court recently opened up competition for Yaz from generics****, DrugRisks cautions patients that blood clots have been linked to the chemical drospirenone, which is used in both brand name and generic formulations.

Lawyers are still helping those affected file a claim. Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugRisks Center or speak with a lawyer about their legal options.

Due to the specialized nature of federal MDL drug injury cases, DrugRisks cautions that patients should seek a lawyer with experience in this litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, side effects and litigation news related to Yaz or Yasmin, or to speak with a lawyer.

*BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
**FDA, 10/27/11, fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
***Bayer 2/28/13; annualreport2012.bayer.com/en/legal-risks.aspx
****Business Week, 4/16/13; businessweek.com/news/2013-04-16/bayer-patent-on-yaz-birth-control-pill-ruled-invalid

Read the full story at http://www.prweb.com/releases/DrugRisks-Yaz-Side/Effects-Center/prweb10777913.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
2. Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes
3. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
4. DrugRisks Update: Yaz Class Action Begins in Canada as Settlements Continue in U.S.
5. DrugRisks Update: Warning Added to Pradaxa For Blood Condition
6. DrugRisks Update: Use of NuvaRing Drops Amid Injury Allegations
7. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
8. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
9. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
10. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
11. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... PISCATAWAY, N.J. (PRWEB) , ... February 08, 2016 ... ... of protective footwear and clothing, announced expansion into Canada to provide its range ... has opened a sales office in Quebec City that will provide bilingual customer ...
(Date:2/8/2016)... GA (PRWEB) , ... February ... ... technology and security executive networking and relationship-marketing firm, announced today that nominations ... 2016 Information Security Executive® (ISE®) West Awards. , Awards include the ...
(Date:2/8/2016)... ... 2016 , ... GrassrootsHealth published data from its D*action public ... in the GrassrootsHealth cohort with substantially higher vitamin D levels than a cohort ... states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits of vitamin ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... The ... annually in this country. The AutismOne 2016 Conference, which is being held May 25-29 ... often won’t hear elsewhere about helpful interventions and causes of chronic illness in children. ...
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd ... to his medical and surgical expertise. Technically known as deoxycholic acid or previously ... as a non-surgical alternative for reduction of fat below the chin (aka the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- http://www.researchandmarkets.com/research/x6mkjm/knee ) has announced the ... by Product Type (Primary (Cemented & Cementless), Partial, ... Japan, Bric, Turkey, Indonesia - Global Analysis and ... --> http://www.researchandmarkets.com/research/x6mkjm/knee ) has announced ... Market by Product Type (Primary (Cemented & Cementless), ...
(Date:2/8/2016)...  Avista Pharma Solutions ("Avista Pharma") announced today that ... Officer (CFO). Mr. Setzer is a finance and operations ... roles within growing technology and life science companies. Prior ... Director of Finance at INC Research, a publicly traded ... . Previously, Mr. Setzer served as CFO of Expression ...
(Date:2/8/2016)... Therapeutics, Inc. announced today that the United States Patent and ... the use of NephroFlow to treat acute kidney injury (AKI). ... "We are pleased to secure our rights to such a ... HemaFlo,s founder, said, "We are pleased to secure our rights ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are pleased ...
Breaking Medicine Technology: